113 related articles for article (PubMed ID: 7511931)
1. Suppression of allograft responses by combining alloantigen-specific i.v. pre-sensitization with suboptimal doses of rapamycin.
Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
Int Immunol; 1994 Jan; 6(1):93-9. PubMed ID: 7511931
[TBL] [Abstract][Full Text] [Related]
2. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506.
Iwata H; Kitagawa S; Sato S; Kosugi A; Hirose H; Hamaoka T; Shearer GM; Fujiwara H
Transplantation; 1993 Jul; 56(1):173-80. PubMed ID: 7687396
[TBL] [Abstract][Full Text] [Related]
3. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
[No Abstract] [Full Text] [Related]
4. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
[TBL] [Abstract][Full Text] [Related]
5. Both T and non-T cells with proliferating potentials are effective in inducing suppression of allograft responses by alloantigen-specific intravenous presensitization combined with suboptimal doses of 15-deoxyspergualin.
Tahara H; Iwanami N; Tabata N; Matsumura H; Matsuura T; Kurita T; Miyazawa M
Transpl Immunol; 2004; 13(1):25-32. PubMed ID: 15203125
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
[TBL] [Abstract][Full Text] [Related]
7. The lymphoid cell populations required for induction of tolerance of different subsets of alloantigen-reactive T cells.
Sato S; Iwata H; Kitagawa S; Kokudo S; Okuno K; Hamaoka T; Fujiwara H
Transplantation; 1991 Nov; 52(5):862-7. PubMed ID: 1835197
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
Yang TY; Sun Y; Langnas AN; Zhao Y
Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
[TBL] [Abstract][Full Text] [Related]
10. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
[TBL] [Abstract][Full Text] [Related]
11. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
[TBL] [Abstract][Full Text] [Related]
12. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
[TBL] [Abstract][Full Text] [Related]
13. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
15. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
[TBL] [Abstract][Full Text] [Related]
16. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo CK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
20. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
